XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Subordinate Voting Shares (as converted)
Share
Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings (Deficit)
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2022   339,983,374        
Beginning balance at Dec. 31, 2022 $ 1,341,550   $ 1,665,957 $ (8) $ (324,399) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   1,104,515        
Share-based compensation 9,391   9,391      
Issuance of shares to relieve liability obligations, net (in shares)   816,021        
Issuance of shares to relieve liability obligations, net 2,610   2,610      
Foreign Currency Translation Adjustment (4)     (4)    
Contingent consideration & other adjustments to purchase accounting (in shares)   1,625,546        
Net Income (Loss) (40,062)       (40,140) 78
Ending balance (in shares) at Sep. 30, 2023   343,529,456        
Ending balance at Sep. 30, 2023 1,313,485   1,677,958 (12) (364,539) 78
Beginning balance (in shares) at Jun. 30, 2023   343,367,514        
Beginning balance at Jun. 30, 2023 1,326,344   1,673,049 (8) (346,697) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   161,942        
Share-based compensation 4,909   4,909      
Foreign Currency Translation Adjustment (4)     (4)    
Net Income (Loss) (17,764)       (17,842) 78
Ending balance (in shares) at Sep. 30, 2023   343,529,456        
Ending balance at Sep. 30, 2023 1,313,485   1,677,958 (12) (364,539) 78
Beginning balance (in shares) at Dec. 31, 2023   344,074,096        
Beginning balance at Dec. 31, 2023 1,240,080   1,681,840 (13) (441,747) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   2,404,096        
Share-based compensation 12,550   12,550      
Issuance of shares in conjunction with acquisitions (in shares)   10,416,041        
Issuance of shares in conjunction with acquisitions 34,453   34,453      
Foreign Currency Translation Adjustment 14     14    
Contingent consideration & other adjustments to purchase accounting (in shares)   31,181        
Distributions paid to non-controlling interest holders (226)         (226)
Net Income (Loss) (69,153)       (69,153)  
Ending balance (in shares) at Sep. 30, 2024   356,925,414        
Ending balance at Sep. 30, 2024 1,217,718   1,728,843 1 (510,900) (226)
Beginning balance (in shares) at Jun. 30, 2024   346,417,144        
Beginning balance at Jun. 30, 2024 1,221,392   1,689,723 2 (468,333) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   92,229        
Share-based compensation 4,667   4,667      
Issuance of shares in conjunction with acquisitions (in shares)   10,416,041        
Issuance of shares in conjunction with acquisitions 34,453   34,453      
Foreign Currency Translation Adjustment (1)     (1)    
Distributions paid to non-controlling interest holders (226)         (226)
Net Income (Loss) (42,567)       (42,567)  
Ending balance (in shares) at Sep. 30, 2024   356,925,414        
Ending balance at Sep. 30, 2024 $ 1,217,718   $ 1,728,843 $ 1 $ (510,900) $ (226)